GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Interpace Biosciences Inc (STU:PF42) » Definitions » Cyclically Adjusted Book per Share

Interpace Biosciences (STU:PF42) Cyclically Adjusted Book per Share : €24.83 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Interpace Biosciences Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Interpace Biosciences's adjusted book value per share for the three months ended in Mar. 2024 was €-12.853. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €24.83 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Interpace Biosciences's average Cyclically Adjusted Book Growth Rate was -51.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -39.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -33.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was -26.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Interpace Biosciences was 4.90% per year. The lowest was -39.30% per year. And the median was -16.20% per year.

As of today (2024-06-07), Interpace Biosciences's current stock price is €1.23. Interpace Biosciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €24.83. Interpace Biosciences's Cyclically Adjusted PB Ratio of today is 0.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Interpace Biosciences was 0.71. The lowest was 0.01. And the median was 0.04.


Interpace Biosciences Cyclically Adjusted Book per Share Historical Data

The historical data trend for Interpace Biosciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interpace Biosciences Cyclically Adjusted Book per Share Chart

Interpace Biosciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 184.11 124.14 91.70 39.16 29.50

Interpace Biosciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 49.99 41.51 - 29.50 24.83

Competitive Comparison of Interpace Biosciences's Cyclically Adjusted Book per Share

For the Diagnostics & Research subindustry, Interpace Biosciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interpace Biosciences's Cyclically Adjusted PB Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Interpace Biosciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Interpace Biosciences's Cyclically Adjusted PB Ratio falls into.



Interpace Biosciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Interpace Biosciences's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-12.853/131.7762*131.7762
=-12.853

Current CPI (Mar. 2024) = 131.7762.

Interpace Biosciences Quarterly Data

Book Value per Share CPI Adj_Book
201406 140.626 100.560 184.281
201409 128.444 100.428 168.538
201412 106.237 99.070 141.310
201503 94.792 99.621 125.388
201506 54.894 100.684 71.846
201509 31.232 100.392 40.996
201512 67.763 99.792 89.481
201603 41.067 100.470 53.863
201606 29.367 101.688 38.056
201609 -7.257 101.861 -9.388
201612 28.449 101.863 36.803
201703 34.166 102.862 43.770
201706 16.101 103.349 20.530
201709 13.321 104.136 16.857
201712 12.102 104.011 15.333
201803 11.572 105.290 14.483
201806 11.705 106.317 14.508
201809 10.913 106.507 13.502
201812 4.732 105.998 5.883
201903 8.310 107.251 10.210
201906 7.143 108.070 8.710
201909 5.609 108.329 6.823
201912 -1.028 108.420 -1.249
202003 -8.885 108.902 -10.751
202006 0.372 108.767 0.451
202009 -14.355 109.815 -17.226
202012 -5.895 109.897 -7.069
202103 -16.223 111.754 -19.129
202106 -7.205 114.631 -8.283
202109 -7.870 115.734 -8.961
202112 -8.948 117.630 -10.024
202203 -9.526 121.301 -10.349
202206 -10.724 125.017 -11.304
202209 -14.650 125.227 -15.416
202212 -13.857 125.222 -14.582
202303 -13.548 127.348 -14.019
202306 -13.317 128.729 -13.632
202309 -13.622 129.860 -13.823
202312 -12.996 129.419 -13.233
202403 -12.853 131.776 -12.853

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Interpace Biosciences  (STU:PF42) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Interpace Biosciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.23/24.83
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Interpace Biosciences was 0.71. The lowest was 0.01. And the median was 0.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Interpace Biosciences Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Interpace Biosciences's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Interpace Biosciences (STU:PF42) Business Description

Traded in Other Exchanges
Address
300 Interpace Parkway, Morris Corporate Center 1, Building C, Parsippany, NJ, USA, 07054
Interpace Biosciences Inc is engaged in the life sciences industry. It provides molecular diagnostics, bioinformatics, and pathology services for the evaluation of the risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. The company develops and commercializes genomic tests and related first-line assays principally focused on the early detection of patients with indeterminate biopsies and at high risk of cancer using the latest technology. It operates under one segment which is the business of developing and selling diagnostic clinical services.

Interpace Biosciences (STU:PF42) Headlines

No Headlines